Fig. 1From: Clinical development innovation in rare diseases: lessons learned and best practices from the DevelopAKUre consortiumPhase 3 study (SONIA 2) recruitment of 139 patients in a rare disease within 9 months demonstrating a constant recruitment rate throughout the periodBack to article page